Targeted brain delivery of RVG29‐modified rifampicin‐loaded nanoparticles for Alzheimer's disease treatment and diagnosis

• Main Authors: Ruiyi Zhou (Author), Lihong Zhu (Author), Zhaohao Zeng (Author), Rixin Luo (Author), Jiawei Zhang (Author), Rui Guo (Author), Lei Zhang (Author), Qunying Zhang (Author), Wei Bi (Author)
• Format: Book
• Published: Wiley, 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Alzheimer's disease (AD) is an aging‐related neurodegenerative disease. The main pathological features of AD are β‐amyloid protein (Aβ) deposition and tau protein hyperphosphorylation. Currently, there are no effective drugs for the etiological treatment of AD. Rifampicin (RIF) is a se...